YOKNEAM, ISRAEL and TORONTO -- (MARKET WIRE) -- February 05, 2007 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos™ combined-energy medical aesthetic devices, today announced the initiation of a multi-center clinical study with Obagi Medical Products, Inc. (NASDAQ: OMPI), a California-based company, and a leader in aesthetic and therapeutic skin health care.
